PROLOCK

What this means for you

This application is over — abandoned 04 Dec 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

88693687

Mark type

Stylized text

Filed

15 Nov 2019

Published for opposition

08 Sept 2020

Abandoned

04 Dec 2023

Attorney of record

Steven A. Abreu

Goods and services

• Class 005 — Pharmaceuticals: biomedical compounds for medical purposes, namely, amino acids, peptides, stapled peptides, and synthetic peptides, in particular amino acids for the medical treatment of cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions; biomedical compounds for medical purposes, namely, miniproteins and cell-penetrating miniproteins (CPMPs) arrays for diagnosing cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions

Owner

• PARABILIS MEDICINES, INC., CAMBRIDGE, MA, US
• Fog Pharmaceuticals, Inc., Cambridge, MA, US
• Fog Pharmaceuticals, Inc., Cambridge, MA, US

Prosecution history

• 19 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 19 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 19 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 06 Nov 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
• 04 Dec 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 04 Dec 2023 — ABANDONMENT - NO USE STATEMENT FILED
• 20 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 19 Apr 2023 — SOU EXTENSION 5 GRANTED
• 13 Apr 2023 — SOU EXTENSION 5 FILED
• 19 Apr 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
• 13 Apr 2023 — SOU TEAS EXTENSION RECEIVED
• 07 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 05 Oct 2022 — SOU EXTENSION 4 GRANTED
• 05 Oct 2022 — SOU EXTENSION 4 FILED
• 05 Oct 2022 — SOU TEAS EXTENSION RECEIVED